The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 26, 2021

Filed:

Nov. 22, 2017
Applicant:

Dana-farber Cancer Institute, Inc., Boston, MA (US);

Inventors:

James Bradner, Weston, MA (US);

Dennis Buckley, Boston, MA (US);

Mette Ishoey Rosenbaum, Alleroed, DK;

Georg Winter, Vienna, AT;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); C07D 471/04 (2006.01); C07D 401/14 (2006.01); C07D 495/04 (2006.01); A61K 47/54 (2017.01); C07D 417/14 (2006.01); C07D 513/04 (2006.01); A61K 45/06 (2006.01); C07D 209/34 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 45/06 (2013.01); A61K 47/545 (2017.08); A61K 47/555 (2017.08); C07D 209/34 (2013.01); C07D 401/14 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 495/04 (2013.01); C07D 513/04 (2013.01);
Abstract

The present application provides bifunctional compounds of Formula (X): or an enantiomer, diastereomer, or stereoisomer thereof, or pharmaceutically acceptable salt, hydrate, solvate, or prodrug thereof, which act as protein degradation inducing moieties for protein kinases. The present application also relates to methods for the targeted degradation of one or more protein kinases through the use of the bifunctional compounds that link a ubiquitin ligase-binding moiety to a ligand that is capable of binding to one or more protein kinases which can be utilized in the treatment of disorders modulated by protein kinases.


Find Patent Forward Citations

Loading…